A dose-finding, cross-over study to evaluate the effect of a Nestorone®/Estradiol transdermal gel delivery on ovulation suppression in normal ovulating women
Authors:
- 1 October 2015
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 92 (4) , 289-297
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Acceptability of the nestorone®/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introductionContraception, 2014
- What matters most? The content and concordance of patients' and providers' information priorities for contraceptive decision makingContraception, 2014
- Women's preferences for contraceptive counseling and decision makingContraception, 2013
- Sex hormone‐binding globulin as a marker for the thrombotic risk of hormonal contraceptivesJournal of Thrombosis and Haemostasis, 2012
- Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family GrowthContraception, 2008
- Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variablesContraception, 2008
- Effects of Oral and Transvaginal Ethinyl Estradiol on Hemostatic Factors and Hepatic Proteins in a Randomized, Crossover StudyThe Journal of Clinical Endocrinology & Metabolism, 2007
- Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism riskThe Lancet, 2003
- Nestorone®: a progestin with a unique pharmacological profileSteroids, 2000
- Biological Effects of Estradiol-17β in Postmenopausal Women: Oral Versus percutaneous AdministrationThe Journal of Clinical Endocrinology & Metabolism, 1986